Direct effects of esmolol and landiolol on cardiac function, coronary vasoactivity, and ventricular electrophysiology in guinea-pig hearts

Journal of Pharmacological Sciences

Volumn 118, Issue 2, 2012, Pages 255-265

  Shibata, Shigehiro ^a   Okamoto, Yosuke ^a   Endo, Shigeatsu ^b   Ono, Kyoichi ^a  

^a AKITA UNIVERSITY   (Japan)

^b IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Coronary perfusion pressure; Esmolol; Landiolol; Langendorff perfusion; Patch clamp

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; CALCIUM CHANNEL L TYPE; DELAYED RECTIFIER POTASSIUM CHANNEL; ESMOLOL; LANDIOLOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPUTER SIMULATION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; GUINEA PIG; HEART ELECTROPHYSIOLOGY; HEART FUNCTION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CELL; HEART MUSCLE POTENTIAL; HEART PERFORMANCE; HEART RATE; ION CURRENT; ISOLATED HEART; NONHUMAN;

EID: 84857599755     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.11202FP     Document Type: Article

References (28)

1. Mio Y. [New ultra-short-acting beta-blockers: landiolol and esmolol - the effects on cardiovascular system]. Masui. 2006;55: 841-848. (text in Japanese with English abstract)
2. Iguchi S, Iwamura H, Nishizaki M, Hayashi A, Senokuchi K, Kobayashi K, et al. Development of a highly cardioselective ultra short-acting beta-blocker, ONO-1101. Chem Pharm Bull (Tokyo). 1992;40:1462-1469.
3. Yamakage M, Iwasaki S, Jeong SW, Satoh J, Namiki A. Beta-1 selective adrenergic antagonist landiolol and esmolol can be safely used in patients with airway hyperreactivity. Heart Lung. 2009;38:48-55.
4. de Montmollin E, Aboab J, Mansart A, Annane D. Bench-tobedside review: beta-adrenergic modulation in sepsis. Crit Care. 2009;13:230.
5. Arlock P, Wohlfart B, Sjoberg T, Steen S. The negative inotropic effect of esmolol on isolated cardiac muscle. Scand Cardiovasc J. 2005;39:250-254. (Pubitemid 41358594)
6. Wiest D. Esmolol. A review of its therapeutic efficacy and pharmacokinetic characteristics. Clin Pharmacokinet. 1995;28:190-202.
7. Sugiyama A, Takahara A, Hashimoto K. Electrophysiologic, cardiohemodynamic and beta-blocking actions of a new ultrashort- acting beta-blocker, ONO-1101, assessed by the in vivo canine model in comparison with esmolol. J Cardiovasc Pharmacol. 1999;34:70-77. (Pubitemid 29296139)
8. Sasao J, Tarver SD, Kindscher JD, Taneyama C, Benson KT, Goto H. In rabbits, landiolol, a new ultra-short-acting betablocker, exerts a more potent negative chronotropic effect and less effect on blood pressure than esmolol. Can J Anaesth. 2001;48:985-989. (Pubitemid 34092918)
9. Ikeshita K, Nishikawa K, Toriyama S, Yamashita T, Tani Y, Yamada T, et al. Landiolol has a less potent negative inotropic effect than esmolol in isolated rabbit hearts. J Anesth. 2008; 22:361-366.
10. Muraki K, Nakagawa H, Nagano N, Henmi S, Kawasumi H, Nakanishi T, et al. Effects of ONO-1101, a novel beta-antagonist, on action potential and membrane currents in cardiac muscle. J Pharmacol Exp Ther. 1996;278:555-563. (Pubitemid 27167019)
11. + current in guinea pig ventricular cells. J Pharmacol Sci. 2004;95:363-373.
12. Bouchard RA, Clark RB, Giles WR. Effects of action potential duration on excitation-contraction coupling in rat ventricular myocytes. Action potential voltage-clamp measurements. Circ Res. 1995;76:790-801.
13. + channels in rat sensory neurons. Eur J Anaesthesiol. 2009;26:196-200.
14. Fallouh HB, Bardswell SC, McLatchie LM, Shattock MJ, Chambers DJ, Kentish JC. Esmolol cardioplegia: the cellular mechanism of diastolic arrest. Cardiovasc Res. 2010;87:552-560.
15. de Bruijn NP, Reves JG, Croughwell N, Clements F, Drissel DA. Pharmacokinetics of esmolol in anesthetized patients receiving chronic beta blocker therapy. Anesthesiology. 1987;66:323-326. (Pubitemid 17095256)
16. Adamson PC, Rhodes LA, Saul JP, Dick M 2nd, Epstein MR, Moate P, et al. The pharmacokinetics of esmolol in pediatric subjects with supraventricular arrhythmias. Pediatr Cardiol. 2006;27:420-427. (Pubitemid 44222393)
17. Sintetos AL, Hulse J, Pritchett EL. Pharmacokinetics and pharmacodynamics of esmolol administered as an intravenous bolus. Clin Pharmacol Ther. 1987;41:112-117. (Pubitemid 17008139)
18. Jacobs JR, Croughwell ND, Goodman DK, White WD, Reves JG. Effect of hypothermia and sampling site on blood esmolol concentrations. J Clin Pharmacol. 1993;33:360-365. (Pubitemid 23141534)
19. Deng CY, Lin SG, Zhang WC, Kuang SJ, Qian WM, Wu SL, et al. Esmolol inhibits Na+ current in rat ventricular myocytes. Methods Find Exp Clin Pharmacol. 2006;28:697-702. (Pubitemid 46225636)
20. Roth E, Matos G, Guarnieri C, Papp B, Varga J. Influence of the beta-blocker therapy on neutrophil superoxide generation and platelet aggregation in experimental myocardial ischemia and reflow. Acta Physiol Hung. 1995;83:163-170.
21. Laustiola K, Seppala E, Nikkari T, Vapaatalo H. Exercise-induced increase in plasma arachidonic acid and thromboxane B2 in healthy men: effect of beta-adrenergic blockade. J Cardiovasc Pharmacol. 1984;6:449-454. (Pubitemid 14109195)
22. Yavascaoglu B, Kaya FN, Ozcan B. Esmolol pretreatment reduces the frequency and severity of pain on injection of rocuronium. J Clin Anesth. 2007;19:413-417. (Pubitemid 47633157)
23. Matsuoka S, Sarai N, Kuratomi S, Ono K, Noma A. Role of individual ionic current systems in ventricular cells hypothesized by a model study. Jpn J Physiol. 2003;53:105-123. (Pubitemid 36950537)
24. Magyar J, Bányász T, Szigligeti P, Körtvély A, Jednákovits A, Nánási PP. Electrophysiological effects of bimoclomol in canine ventricular myocytes. Naunyn Schmiedebergs Arch Pharmacol. 2000;361:303-310. (Pubitemid 30106343)
25. Goldstein SA, Bayliss DA, Kim D, Lesage F, Plant LD, Rajan S. International Union of Pharmacology. LV. Nomenclature and molecular relationships of two-P potassium channels. Pharmacol Rev. 2005;57:527-540. (Pubitemid 43036439)
26. Gurney A, Manoury B. Two-pore potassium channels in the cardiovascular system. Eur Biophys J. 2009;38:305-318.
27. Theochari E, Xanthos T, Papadimitriou D, Demestiha T, Condilis N, Tsirikos-Karapanos N, et al. Selective beta blockade improves the outcome of cardiopulmonary resuscitation in a swine model of cardiac arrest. Ann Ital Chir. 2008;79:409-414.
28. Chauhan S, Saxena N, Rao BH, Singh RS, Bhan A. A comparison of esmolol & diltiazem for heart rate control during coronary revascularisation on beating heart. Ann Card Anaesth. 2000;3: 28-31.